http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110713500-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 |
| filingDate | 2019-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110713500-B |
| titleOfInvention | Palladium complex using 2-benzoylpyridine thiosemicarbazone and synthetic method thereof |
| abstract | The invention discloses a palladium complex of thiosemicarbazone by 2-benzoylpyridine and a synthetic method thereof, wherein the synthetic method is to take 2-benzylRespectively mixing and reacting acyl pyridine with 4, 4-dimethyl-3-thiosemicarbazide and 3-pyrrole-3-thiosemicarbazide to prepare a ligand; taking the prepared ligand and PdCl 2 The reaction gave palladium complexes C1 and C2. The invention further performs in vitro proliferation inhibition activity experiments on the synthesized palladium complex C1-C2, and the results show that the synthesized palladium complex has generally good in vitro activity, shows good inhibition activity, has little toxic effect on normal cells of human, and is suitable for preparing high-efficiency and low-toxicity antitumor drugs. |
| priorityDate | 2019-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.